10th Circ. Won't Revisit MusclePharm's SEC Probe Coverage
The Tenth Circuit on Monday declined to rehear a case that found the formal announcement of a U.S. Securities and Exchange Commission investigation didn't trigger coverage for MusclePharm Corp. under a...To view the full article, register now.
Already a subscriber? Click here to view full article